Acute rheumatic fever and rheumatic heart disease.
Nature reviews. Disease primers·
- DOI
- 10.1038/s41572-026-00685-y
- PMID
- 41748639
- PMCID
- —
- OpenAlex
- W7131615947
- Study type
- Journal article
- Publisher
- Publisher unavailable
- Article type
- journal-article
- Integrity
- current
Why this research matters now
The condition represents a significant source of preventable cardiovascular morbidity and mortality worldwide, underscoring the necessity for sustained institutional funding and strategic policy alignment to reach global elimination objectives.
Structured evidence summary
Research question
What constitutes the current scientific understanding, clinical management framework, and remaining implementation barriers for acute rheumatic fever and rheumatic heart disease?
Study design
This publication functions as a peer-reviewed narrative review synthesizing historical research, contemporary clinical guidelines, and ongoing therapeutic developments.
Population and setting
The discussion centers on populations residing in low- and middle-income nations, with particular emphasis on regions experiencing high disease burdens and limited surgical infrastructure.
Main findings
Collaborative investigations have clarified how superficial bacterial infections contribute to disease onset and progression. Clinical evaluation has improved through updated imaging standards and international management protocols. Despite these advances, substantial inequities in therapeutic access and specialized surgical services continue to impede broader disease control efforts.
Public-health relevance
The condition represents a significant source of preventable cardiovascular morbidity and mortality worldwide, underscoring the necessity for sustained institutional funding and strategic policy alignment to reach global elimination objectives.
Important limitations
Access to specialized cardiac interventions remains severely restricted in several heavily affected regions. The transition from validated clinical protocols to consistent patient-level outcomes requires further investigation into practical implementation strategies.
GIDS interpretation
This review provides a centralized reference point for monitoring scholarly discourse on streptococcal sequelae, outlining historical research trajectories, updated diagnostic standards, and recognized infrastructural deficits relevant to future literature searches.
Related GIDS surveillance
Literature context does not validate, explain, or change a surveillance signal. Exact and contextual relationships are shown separately.
Evidence relationships
This article has 6 auditable classifier relationships to diseases, places, topics, and study design.